-

Valtris Specialty Chemicals Announces New Chief Human Resources Officer

Chemical Industry veteran Clint Shephard appointed; will be located in new Midland, Michigan office

INDEPENDENCE, Ohio--(BUSINESS WIRE)--Valtris Specialty Chemicals, a leading global manufacturer of a comprehensive portfolio of specialty additives, announced today the appointment of Clint Shephard as the company’s new Chief Human Resources Officer. Mr. Shephard will play a key role in leading the company’s global talent strategy. Mr. Shephard will be based in the company’s new office in Midland, Michigan.

Mr. Shephard most recently served as Senior Director of Human Resources at Myers Industries Inc. (NYSE: MYE), where he led HR strategy for a leading manufacturer of sustainable plastic and metal products and solutions. Prior to his tenure at Myers, he spent 15 years at The Dow Chemical Company (NYSE: DOW), including serving as a Global HR Leader, where he led talent strategy, organizational effectiveness, and workforce excellence. He holds a Bachelor of Business Administration and an MBA from Saginaw Valley State University.

“I have worked with Clint on several occasions over the past 20 years and have seen firsthand the impact he brings as a leader,” said Mike McGaugh, Valtris’ CEO. “He is a seasoned HR executive with a strong track record of building organizations that drive growth and profitability, and I am confident he will do the same at Valtris. Bringing Clint onto our leadership team is an important step in our transformation. He combines a collaborative, pragmatic approach with deep expertise in talent development, and I believe he will be a valuable partner as we continue to build a strong company with a bright future.”

“I look forward to partnering with the team to build on Valtris’ strong culture, further develop our talent, and help drive the company’s strategic ambitions,” said Mr. Shephard. “Valtris has a compelling vision for growth, and I’m excited to contribute to strengthening the organization and supporting its people around the world.”

ABOUT VALTRIS

Valtris, headquartered in Independence, Ohio, is a global leader in specialty performance additives, offering innovative sustainable solutions and products to customers around the world. With strong technical expertise and best-in-class formulation capabilities, Valtris develops products that provide essential performance properties to polymer end-use applications in the coatings, adhesives and sealants, pharmaceuticals, oil and gas, lubricant, and personal care industries. The Company operates seven manufacturing locations and employs approximately 600 people across North America, Europe and Asia. For more information, please visit www.valtris.com.

Contacts

Sarah Ball
sball@gregoryagency.com
(508) 641-2445

Valtris Specialty Chemicals


Release Versions

Contacts

Sarah Ball
sball@gregoryagency.com
(508) 641-2445

More News From Valtris Specialty Chemicals

SK Capital Partners Completes the Sale of Phoenix Flavors & Fragrances to Turpaz Industries

NORWOOD, N.J.--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the material sciences, specialty ingredients, and life sciences sectors, announced today that it has completed the sale of Phoenix Flavors & Fragrances Inc. (“Phoenix” or the “Company”) to Turpaz Industries Ltd (TLV: TRPZ), a global developer, manufacturer, and marketer of specialty fragrance, flavor, and natural ingredient solutions for consumer and in...

SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG

NEW YORK--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have completed the sale of Noramco, Extractas Biosciences, and Purisys of the Noramco Group (“Noramco” or the “Company”) to Siegfried Holding AG (SIX: SFZN; “Siegfried”), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry....

SK Capital Partners Appoints Jason Grapski as Managing Director, Portfolio Excellence

NEW YORK--(BUSINESS WIRE)--SK Capital Partners (“SK Capital”), a private investment firm focused on the material sciences, specialty ingredients, and life sciences sectors, announced today that Jason Grapski has joined the firm as Managing Director, Portfolio Excellence. In this position, Mr. Grapski will lead the firm’s approach to portfolio company improvement, focusing on enhancing execution and accelerating the realization of each company’s strategic, operational and financial objectives. M...
Back to Newsroom